SHEN Jing, LIU Zhikai, GUAN Hui, ZHEN Hongnan, SUN Xiansong, JIANG Fei, ZHANG Yue, YU Lang, ZHANG Jie, ZHANG Fuquan. Total Marrow and Lymphoid Irradiation: A New Technology Assisting in Myeloablating Before Hematopoietic Stem Cell Transplantation[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 895-899. DOI: 10.12290/xhyxzz.2022-0503
Citation: SHEN Jing, LIU Zhikai, GUAN Hui, ZHEN Hongnan, SUN Xiansong, JIANG Fei, ZHANG Yue, YU Lang, ZHANG Jie, ZHANG Fuquan. Total Marrow and Lymphoid Irradiation: A New Technology Assisting in Myeloablating Before Hematopoietic Stem Cell Transplantation[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 895-899. DOI: 10.12290/xhyxzz.2022-0503

Total Marrow and Lymphoid Irradiation: A New Technology Assisting in Myeloablating Before Hematopoietic Stem Cell Transplantation

More Information
  • Corresponding author:

    LIU Zhikai, E-mail: liuzk2009@126.com

  • Received Date: September 03, 2022
  • Accepted Date: November 21, 2022
  • Issue Publish Date: July 29, 2023
  • This paper reports the first case of myelodysplastic syndromes combined with myeloid sarcoma for which the department of radiotherapy used total marrow and lymphoid irradiation (TMLI) to assist in myeloablating. Radiotherapy localization and target area delineation were carried out before treatment and the entire process of TMLI treatment was designed using the TOMO therapy. Radiotherapy was performed successfully for targeted irradiation of the total bone marrow and lymph nodes. The patient felt comfortable during the treatment process and good pretreatment effects were achieved. The treatment time (45 min-1 h per session) was significantly shorter than that during total body irradiation (TBI)(3-4 h per session), the irradiation dose rate (800 cGy/min) was significantly increased compared to TBI (5-30 cGy/min), and oral mucosal inflammation and gastrointestinal reactions were mild after treatment. This article discusses the treatment process of this case and TMLI technology, to provide reference for the whole process design and important parameters for further treatment of more patients.
  • [1]
    张红, 邱小平, 杨振, 等. 23例X线全身照射患者的照射方法及剂量学分析[J]. 中国医学物理学杂志, 2011, 28: 3-7. https://www.cnki.com.cn/Article/CJFDTOTAL-YXWZ201106015.htm
    [2]
    陈喜林, 张伟京, 俞受程, 等. 全淋巴区照射在恶性淋巴瘤造血干细胞移植治疗中的放射生物效应和临床应用[J]. 中华放射医学与防护杂志, 2002, 22: 116-117. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHFS200202022.htm
    [3]
    Giralt S. TMLI: a better TBI or more of the same?[J]. Blood, 2011, 117: 9-11. DOI: 10.1182/blood-2010-10-312132
    [4]
    Zhao X, Lu X, Tang L, et al. Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience[J]. Leuk Lymphoma, 2020, 61: 2859-2867. DOI: 10.1080/10428194.2020.1789621
    [5]
    Sarradin V, Simon L, Huynh A, et al. Total body irradiation using Helical Tomotherapy: Treatment technique, dosimetric results and initial clinical experience[J]. Cancer Radiother, 2018, 1: 17-24.
    [6]
    Bao Z, Zhao H, Wang D, et al. Feasibility of a novel dose fractionation strategy in TMI/TMLI[J]. Radiat Oncol, 2018, 13: 248-257. DOI: 10.1186/s13014-018-1201-0
    [7]
    Paix A, Antoni D, Waissi W, et al. Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review[J]. Crit Rev Oncol Hematol, 2018, 123: 138-148. DOI: 10.1016/j.critrevonc.2018.01.011
    [8]
    Mancosu P, Navarria P, Muren LP, et al. Development of an Immobilization Device for Total Marrow Irradiation[J]. Pract Radiat Oncol, 2021, 11: e98-e105. DOI: 10.1016/j.prro.2020.02.012
    [9]
    Dibs K, Sim AJ, Penagaricano JA, et al. Gonadal-sparing total body irradiation with the use of helical tomotherapy for nonmalignant indications[J]. Rep Pract Oncol Radiother, 2021, 26: 153-158. DOI: 10.5603/RPOR.a2021.0006
    [10]
    Wong JYC, Filippi AR, Scorsetti M, et al. Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia[J]. Lancet Oncol, 2020, 21: e477-e487. DOI: 10.1016/S1470-2045(20)30342-9
    [11]
    孔凡洋, 蔺亚雷, 刘乐乐, 等. 基于螺旋断层治疗的儿童全骨髓全淋巴照射临床研究[J]. 中华放射肿瘤学杂志, 2018, 10: 5-8.
    [12]
    Chilukuri S, Sundar S, Thiyagarajan R, et al. Total marrow and lymphoid irradiation with helical tomotherapy: a practical implementation report[J]. Radiat Oncol J, 2020, 38: 207-216. DOI: 10.3857/roj.2020.00528
    [13]
    Haraldsson A, Engellau J, Lenhoff S, et al. Implementing safe and robust Total Marrow Irradiation using Helical Tomotherapy-A practical guide[J]. Phys Med, 2019, 60: 162-167. DOI: 10.1016/j.ejmp.2019.03.032
    [14]
    Shen J, Wang X, Deng D. et al. Evaluation and improve-ment the safety of total marrow irradiation with helical tomotherapy using repeat failure mode and effects analysis[J]. Radiat Oncol, 2019, 14: 238. DOI: 10.1186/s13014-019-1433-7
    [15]
    Bao Z, Zhao H, Wang D, et al. Feasibility of a novel dose fractionation strategy in TMI/TMLI[J]. Radiat Oncol, 2018, 13: 248-257. DOI: 10.1186/s13014-018-1201-0
    [16]
    Loginova AA, Tovmasian DA, Lisovskaya AO, et al. Optimized Conformal Total Body Irradiation methods with Helical TomoTherapy and Elekta VMAT: Implementation, Imaging, Planning and Dose Delivery for Pediatric Patients[J]. Front Oncol, 2022, 12: 785917-785924.
    [17]
    Sresty N, Gudipudi D, Krishnam Raju A, et al. Total body irradiation of bone marrow transplant using helical TomoTherapy with a focus on the quality of dose contribution at junction target volumes[J]. Strahlenther Onkol, 2021, 197: 722-729.
    [18]
    许森奎, 姚文燕, 胡江, 等. 基于螺旋断层治疗的全身皮肤照射体位固定新技术初步观察[J]. 中华放射肿瘤学杂志, 2021, 30: 5-10.
  • Related Articles

    [1]ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227
    [2]WEI Jiaojiao, LIU Shiwei, DUAN Ruixue, LI Nan, WANG Jiangna. Effects of Vaspin on Pancreatic Beta Cell Function in Type 2 Diabetic Rats by AMPK/mTOR Autophagy Signaling Pathway[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 543-552. DOI: 10.12290/xhyxzz.2022-0183
    [3]LIU Yanting, ZHANG Lu, CHEN Miao, ZHANG Yan, WEI Chong, PAN Boju, ZHAO Jiawei. A Case of Small B-cell Lymphocytic Lymphoma Diagnosed One Year after Evans Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 423-426. DOI: 10.12290/xhyxzz.20200063
    [4]XIAO Nan, LI Zhanfeng, YAO Jianxin, PAN Zhiyao, YAO Zhifeng. Long Non-coding RNA and Cancer Stem Cells[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 373-379. DOI: 10.12290/xhyxzz.20190231
    [5]Teng ZHU, Hong-zhong JIN. mRNA Expression of Methylase and Methyl-CpG Binding Protein in Peripheral Blood Mononuclear Cells from Patients with Generalized Pustular Psoriasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 358-363. DOI: 10.3969/j.issn.1674-9081.2019.04.009
    [6]Wen-ming CHEN. Is Autologous Stem Cell Transplantation the Standard Treatment for Transplant-eligible Patients with Multiple Myeloma?[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(3): 224-227. DOI: 10.3969/j.issn.1674-9081.2018.03.007
    [7]Yuan-yuan JIN, Jun-ling ZHUANG. Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Medicines[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(3): 219-223. DOI: 10.3969/j.issn.1674-9081.2018.03.006
    [8]Hong Yang, Shanshan Hu, Gechong Ruan, Xiaoou Yang, Jiaming Qian. Expression of ARHI and HuR in PANC-1 Cells[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(1): 39-42. DOI: 10.3969/j.issn.1674-9081.2017.01.009
    [9]Xiao-hua SHI, Zhi-yong LIANG, Huan-wen WU, Xin-yu REN, Tong-hua LIU. Effect of RNA Interference Plasmid on the Expression of Oncogene AKT2 in Pancreatic Cancer Cell Line Panc-1[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 102-108. DOI: 10.3969/j.issn.1674-9081.2012.01.021
    [10]Xin-jie BAO, Jun-ji WEI, Ming FENG, Shan LU, Chun-hua ZHAO, Ren-zhi WANG. Effect of Transplantation of Bone Marrow-derived Mesenchymal Stem Cells on the Apoptosis of Neurons in Ischemic Rats[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(1): 19-23. DOI: 10.3969/j.issn.1674-9081.2011.01.004

Catalog

    Article Metrics

    Article views (365) PDF downloads (26) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close